Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

Abstract: Skin cancer is one of the fastest-growing types of cancer worldwide, and early detection is essential for effective treatment and reduced mortality. Conventional diagnostic techniques take a ...

Presentations at the ASCO Annual Meeting 2026 illustrated a strengthening trend toward biomarker-driven, targeted first-line treatments for advanced and metastatic non-small cell lung cancers. Cancers ...

This standalone MATLAB project generates edge groups from images, converts manual polyline annotations into edge-group labels, and trains RF and PCA/SVM classifiers. The repository includes the ...

Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But efforts to find preventive drugs and vaccines are starting to bear fruit. New ...

U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...

CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American ...

Researchers around the world are grappling with a vexing problem: why are so many young people developing cancers once considered the purview of old age? This question was prominent at two of the ...

Norway's Crown Princess was diagnosed with chronic pulmonary fibrosis in 2018 Per Ole Hagen/Getty Crown Princess Mette-Marit of Norway has been placed on the lung transplant waiting list Her health ...

Norway’s Crown Princess Mette-Marit has been placed on a waiting list for a lung transplant after a further ‌deterioration of her health, the royal household said in a statement on Friday. The 52-year ...

Revolution Medicines focuses on developing drugs for RAS-addicted cancers. RAS is a family of proteins that act as molecular switches in controlling cell growth. They can be turned "on" or "off." In ...